Pro Medicus Ltd
ASX:PME

Watchlist Manager
Pro Medicus Ltd Logo
Pro Medicus Ltd
ASX:PME
Watchlist
Price: 249.99 AUD -0.73% Market Closed
Market Cap: 26.1B AUD

Pro Medicus Ltd
Income from Continuing Operations

Last Value
3 Years 3Y CAGR
5 Years 5Y CAGR
10 Years 10Y CAGR
Last Value
3 Years 3Y CAGR
5 Years 5Y CAGR
10 Years 10Y CAGR
Quarterly
Annual
TTM
|
See Also

Pro Medicus Ltd
Income from Continuing Operations Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Income from Continuing Operations CAGR 3Y CAGR 5Y CAGR 10Y
Pro Medicus Ltd
ASX:PME
Income from Continuing Operations
AU$115.2m
CAGR 3-Years
37%
CAGR 5-Years
38%
CAGR 10-Years
43%
Mach7 Technologies Ltd
ASX:M7T
Income from Continuing Operations
-AU$6.2m
CAGR 3-Years
-14%
CAGR 5-Years
N/A
CAGR 10-Years
1%
4DMedical Ltd
ASX:4DX
Income from Continuing Operations
-AU$30.1m
CAGR 3-Years
-7%
CAGR 5-Years
-6%
CAGR 10-Years
N/A
CogState Ltd
ASX:CGS
Income from Continuing Operations
$10.1m
CAGR 3-Years
10%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Alcidion Group Ltd
ASX:ALC
Income from Continuing Operations
AU$1.7m
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
A
Artrya Ltd
ASX:AYA
Income from Continuing Operations
-AU$16.4m
CAGR 3-Years
1%
CAGR 5-Years
-65%
CAGR 10-Years
N/A
No Stocks Found

Pro Medicus Ltd
Glance View

Pro Medicus Ltd, an Australian company founded in 1983, has etched its name in the field of healthcare IT, primarily through its innovative medical imaging software solutions. The brainchild of Dr. Sam Hupert and Anthony Hall, the company originally sought to provide radiology practices with digital solutions for image management and viewing. Over the years, Pro Medicus has meticulously evolved its offerings to become a leader in picture archiving and communication systems (PACS), radiology information systems (RIS), and an expanding range of e-health solutions. Its flagship product, Visage 7, is renowned for delivering fast and sophisticated viewing capabilities, enabling radiologists to efficiently interpret complex imaging data. Under its hood, the company’s technology is powered by advanced streaming capabilities, allowing for large files to be quickly accessed and reviewed, essential for high-demand environments. The monetization model of Pro Medicus largely revolves around licensing agreements for its software, alongside service and support fees, ensuring a steady and recurring revenue stream. The company has successfully leveraged its expertise to penetrate key markets, notably the United States and Europe, where it partners with some of the most prestigious hospitals and research institutions. By focusing on high-end offerings and fostering long-term client relationships, Pro Medicus has cemented a premium positioning in the healthcare IT landscape. The strategic focus on innovation, coupled with a keen understanding of the evolving needs of healthcare providers, allows Pro Medicus to continually refine its services, ensuring it remains at the forefront of technological advancements that ultimately enhance diagnostic efficiency and patient outcomes.

PME Intrinsic Value
41.66 AUD
Overvaluation 83%
Intrinsic Value
Price

See Also

What is Pro Medicus Ltd's Income from Continuing Operations?
Income from Continuing Operations
115.2m AUD

Based on the financial report for Jun 30, 2025, Pro Medicus Ltd's Income from Continuing Operations amounts to 115.2m AUD.

What is Pro Medicus Ltd's Income from Continuing Operations growth rate?
Income from Continuing Operations CAGR 10Y
43%

Over the last year, the Income from Continuing Operations growth was 39%. The average annual Income from Continuing Operations growth rates for Pro Medicus Ltd have been 37% over the past three years , 38% over the past five years , and 43% over the past ten years .

Back to Top